The FDA's approval of the unavailable Comirnaty was a classic bait-and-switch.
Line 1:
Line 1:
−
'''Comirnaty''' is an unavailable [[COVID vaccine]] which was approved by the [[FDA]] on August 23 to give cover to its lack of approval of the [[Pfizer]] [[vaccine]].
+
'''Comirnaty''' is an unavailable [[COVID vaccine]] which was approved by the [[FDA]] on August 23 to give cover to its lack of approval of the [[Pfizer]] [[vaccine]]. The FDA's approval of the unavailable Comirnaty was a classic bait-and-switch.
Comirnaty is still experimental -- the approval is contingent on studies on myocarditis with a 5-year follow-up that will not end until 2-27.
Comirnaty is still experimental -- the approval is contingent on studies on myocarditis with a 5-year follow-up that will not end until 2-27.